论文部分内容阅读
目的调查2014年克拉玛依市中心医院呼吸系统住院患者疾病构成和费用情况,为开展呼吸系统单病种的循证药学研究提供基线数据。方法提取克拉玛依市中心医院信息管理系统2014年呼吸系统单病种的用药和费用构成等数据,用Microsoft Excel 2007统计软件整理分析数据。统计指标包括频数、占比和累计占比。结果 (1)2014年克拉玛依市中心医院呼吸系统住院患者共3 306人次,排名前3的呼吸系统疾病分别是支气管肺炎、肺炎和肺部感染;(2)患者民族比>人口民族比,前3位依次是支气管哮喘(非危重)占40.21%、支气管肺炎占38.14%、慢性阻塞性肺病伴急性加重占36.27%;(3)人均住院日、人均住院费、人均西药费、人均中成药费、人均诊疗费、人均检查费排名前3位依次是肺部感染、慢性阻塞性肺病和支气管哮喘(非危重)。结论基于调查结果,将支气管肺炎、肺部感染、支气管哮喘和慢性阻塞性肺病列为本次呼吸系统循证药学的目标单病种。
Objective To investigate the composition and cost of inpatients with respiratory system in Karamay Central Hospital in 2014 and provide baseline data for evidence-based pharmaco-logical study of single-disease respiratory system. Methods Data were collected from Karamay Central Hospital Information Management System in 2014 for the use of single-disease respiratory system and cost composition, and the data were analyzed with Microsoft Excel 2007 statistical software. Statistical indicators include frequency, proportion and cumulative proportion. Results (1) There were 3,306 hospitalized respiratory patients in Karamay Central Hospital in 2014. The top 3 respiratory diseases were bronchial pneumonia, pneumonia and pulmonary infection. (2) Followed by bronchial asthma (non-critical) accounted for 40.21%, bronchial pneumonia accounted for 38.14%, chronic obstructive pulmonary disease with acute exacerbation accounted for 36.27%; (3) per capita hospitalization days, per capita hospitalization costs, per capita Western drug costs, Per capita treatment fee, per capita examination fee ranked the top 3 followed by lung infection, chronic obstructive pulmonary disease and bronchial asthma (non-critical). Conclusions Based on the findings, bronchial pneumonia, lung infections, bronchial asthma and chronic obstructive pulmonary disease are listed as the single disease target of this evidence-based pharmacogenitor for respiratory system.